Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04498468 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye
A Phase 4 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 77
- Enrollment target
NCT04498468: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.
NCT04498468 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04498468, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 77 participants
- Enrollment target
Study Summary
To determine efficacy and safety profile of dexamethasone 0.4mg lacrimal insert in dry eye related ocular surface inflammation.
Interventions
- DRUG Sustained Release Dexamethasone, 0.4 mg
- OTHER E-Caprolactone-L-Lactide copolymer (PCL) punctal plug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2021-03-16 |
| Est. Completion | 2023-03-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04498468
The ClinicalTrials.gov registry entry for NCT04498468 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sustained Release Dexamethasone, 0.4 mg is the first listed.
NCT04498468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04498468 about?
NCT04498468 is a clinical study titled "Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye". To determine efficacy and safety profile of dexamethasone 0.4mg lacrimal insert in dry eye related ocular surface inflammation.
What is the current status of trial NCT04498468?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 77 participants. The study started on 2021-03-16. Estimated completion is 2023-03-03.
What interventions are being tested in trial NCT04498468?
The interventions under investigation include: Sustained Release Dexamethasone, 0.4 mg (DRUG), E-Caprolactone-L-Lactide copolymer (PCL) punctal plug (OTHER).
Who is sponsoring clinical trial NCT04498468?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.